PRF Technologies (PRFX) Preferred Shares (2019 - 2023)
PRF Technologies' (PRFX) quarterly Preferred Shares came in at $1.1 million in Q4 2023, down 92.56% on a QoQ basis from $15.2 million in Q4 2019.
PRF Technologies (PRFX) Preferred Shares (2019 - 2023) Analysis & Trends
PRF Technologies (PRFX) has 2 years of Preferred Shares data on file, last reported at $1.1 million in Q4 2023.
- Quarterly Preferred Shares changed N/A year-over-year to $1.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.1 million (changed N/A YoY) and the FY2023 annual result came in at $1.1 million, changed N/A from the prior year.
- Preferred Shares eased to $1.1 million in Q4 2023, from $15.2 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $15.2 million in Q4 2019 to a low of $1.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.14 Mn |
| Dec 31, 2019 | 15.25 Mn |